Protecting the Frontline in Biodefense Research: The Special Immunizations Program (2011)
Chapter: Appendix B: Abbreviations and Acronyms
Appendix B
Abbreviations and Acronyms
ACIP Advisory Committee on Immunization Practices
ASPR Assistant Secretary for Preparedness and Response
BARDA Biomedical Advanced Research and Development Authority
BDRP Biological Defense Research Program
BMBL Biosafety in Microbiological and Biomedical Laboratories
BSC Biological safety cabinet
BSL Biosafety level
CBDP Chemical and Biological Defense Program
CBMS Chemical Biological Medical Systems
CBMS-JPMO Chemical Biological Medical Systems Joint Project Management Office
CBRN Chemical, Biological, Radiological, Nuclear
CDC Centers for Disease Control and Prevention
CFR Code of Federal Regulations
cGCP Current Good Clinical Practice
cGMP Current Good Manufacturing Practice
CRDA Cooperative Research and Development Agreement
DARPA Defense Advanced Research Projects Agency
DHS Department of Homeland Security
DIA Defense Intelligence Agency
DOD Department of Defense
DOE U.S. Department of Energy
DSAT Division of Select Agents and Toxins
EEE Eastern equine encephalitis
EKG Electrocardiogram
EMA European Medicines Agency
EUA Emergency Use Authorization
FDA Food and Drug Administration
FFRDC Federally Funded Research and Development Center
FSA Civilian Federal Security Agency
FY Fiscal year
GAO U.S. Government Accountability Office
GOCO Government-owned, contractor-operated
HBV Hepatitis B virus
HHS Department of Health and Human Services
HSC U.S. Homeland Security Council
IAWG U.S. Government Interagency Working Group
ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
IND Investigational New Drug
IOM Institute of Medicine
JPEO-CBD Joint Program Executive Office for Chemical/Biological Defense
JRO Joint Research Office
JSTO Joint Science and Technology Office for Chemical and Biological Defenses
JVAP Joint Vaccine Acquisition Program
LAI Laboratory-associated infection (laboratory-acquired infection)
LRRI Lovelace Respiratory Research Institute
LVS Live vaccine strain
MCM Medical Countermeasure
MEDCOM U.S. Army Medical Command
MOA Memorandum of agreement
MOU Memorandum of understanding
NBACC National Biodefense Analysis and Countermeasures Center
NBFAC National Bioforensic Analysis Center
NBSB National Biodefense Science Board
NIAID National Institute of Allergy and Infectious Diseases
NIH National Institutes of Health
NMRC U.S. Navy Naval Medical Research Center
NRC National Research Council
OMB Office of Management and Budget
OPEO Office of Preparedness and Emergency Operations
OSHA Occupational Safety and Health Administration
PERT Product-enhanced reverse transcriptase
PHEMCE Public Health Emergency Medical Countermeasures Enterprise
PI Principal investigator
PPE Personal protective equipment
PPP Public–private partnership
PCC Policy Coordinating Committee
R&D Research and development
RCE Regional Centers of Excellence
SAE Serious adverse event
SBCCOM U.S. Army Soldier and Biological Chemical Command
SIP Special Immunizations Program
SNS Strategic National Stockpile
TMT Transformational Medical Technologies program
TPP Target product profiles
USAMMDA U.S. Army Medical Materiel Development Activity
USAMRDC U.S. Army Medical Research and Development Command (Subsequently merged with the Medical Material Agency to create USAMRMC)
USAMRIID U.S. Army Medical Research Institute of Infectious Diseases
USAMRMC U.S. Army Medical Research and Materiel Command
USDA U.S. Department of Agriculture
VEE Venezuelan equine encephalitis
WEE Western equine encephalitis
WMDMC Weapons of mass destruction medical countermeasures
WMDMCS Weapons of Mass Destruction Medical Countermeasures Subcommittee
WRS War Research Service
